Amarin | AMRN - Ebitda

Preço das Ações
14.56
Mudança Diária
-0.22 -1.49%
Mensal
-1.09%
Anual
37.62%
Q2 Previsão
14.12




Ebitda Alterar Data
AbbVie USD 5.37B 1.85B 2025-12
Alnylam Pharmaceuticals USD 145.22M 236.56M 2025-12
Amarin USD 12.54M 28.57M 2025-06
AstraZeneca USD 5.67B 1.29B 2026-03
BioCryst Pharmaceuticals USD 51.7M 30.14M 2025-09
DBV Technologies USD -33.48M 5.55M 2025-09
Esperion Therapeutics USD -9.93M 24.99M 2025-09
GlaxoSmithKline GBP 2.77B 1.65B 2026-03
Halozyme Therapeutics USD 21.9M 226.34M 2025-12
Heron Therapeutics USD -3.88M 5.63M 2024-09
Ionis Pharmaceuticals USD -200.02M 42.89M 2025-12
Nektar Therapeutics USD -31.81M 70K 2023-09
Neurocrine Biosciences USD 193.3M 25.1M 2026-03
Novartis USD 5.3B 530M 2026-03